Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology during the agency transition appears above the ClinicalTrials.gov page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:07:21.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:51.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record and blocking access to the trial details.
    Difference
    18%
    Check dated 2026-09-23T00:06:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0 instead of v3.6.6, indicating an update to the site's interface version. This change relates to UI/versioning and does not alter the study details or content.
    Difference
    0.1%
    Check dated 2026-09-15T23:25:42.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, representing a backend/frontend platform update rather than content changes.
    Difference
    0.1%
    Check dated 2026-09-01T19:23:27.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study's list of identifiers now includes '2016 ( U.S. NIH Grant/Contract )', adding NIH grant attribution to the record.
    Difference
    0.1%
    Check dated 2026-08-25T16:31:54.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.